EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Income Statement
NASDAQ:EPRX - Nasdaq - CA29842P1053 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 132.80K | 242.00K | 745.20K | 660.00K | 380.00K | |||
| Operating Expenses | 25.86M | 25.43M | 27.44M | 22.96M | 18.23M | |||
| Research and Development | 13.06M | 14.87M | 19.77M | 17.20M | 9.68M | |||
| Selling, General, and Administrative Expenses | 12.68M | 10.45M | 7.56M | 5.53M | 8.41M | |||
| Operating Income | -25.86M | -25.43M | -27.44M | -22.96M | -18.23M | |||
| Interest Income/Expense | 1.06M | 1.24M | -1.07M | -670.00K | -2.40M | |||
| Other Income/Expense | N/A | -1.90K | -7.40K | N/A | N/A | |||
| Non Recurring Items | -1.58M | -1.57M | -404.10K | -280.00K | -2.74M | |||
| Income Before Taxes | -26.36M | -25.74M | -28.93M | -23.92M | -23.37M | |||
| Income Tax | N/A | 1.80K | 36.40K | N/A | N/A | |||
| Net Income | -26.22M | -25.50M | -28.22M | -23.26M | -22.99M | |||
| EBITDA | -25.72M | -25.32M | -27.33M | -22.77M | -18.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.74 | -0.75 | -1.17 | -1.21 | -1.85 | |||
| Non GAAP EPS | -1.05 | -1.03 | -1.22 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD